- Let's make a deal April 22
Two of the world's biggest drugmakers, Britain's GlaxoSmithKline and Switzerland's Novartis, announced a complex hodgepodge of deals worth at least $25 billion on Tuesday. The main components:
* Novartis agreed to buy Glaxo's oncology business for between $14.5 billion and $16 billion
* Glaxo is buying Novartis' vaccine business for between $5.3 billion and $7.1 billion
* The two companies are combining their consumer health (over-the-counter) divisions, with Glaxo taking 63.5 percent of the joint venture
* Eli Lilly will purchase Novartis' animal health unit for about $5.4 billion
The transactions will let Novartis focus on high-margin businesses like cancer drugs while Glaxo boosts its position in consumer goods and the low-margin, high-volume vaccine market. But the pharmaceutical giants aren't the only drugmakers making high-stakes deals. The Wall Street Journal says the $25 billion worth of transactions cap a 24-hour period where "deals worth, conservatively, $65 billion" were announced, not counting Pfizer's unsolicited $101 billion offer to buy Britain's AstraZeneca.
"The Novartis-Glaxo deal and rumors about a potential AstraZeneca acquisition by Pfizer are giving the pharma sector a decent run this morning," Danish strategist Witold Bahrke tells Bloomberg News. "It's also fueling further M&A expectations."- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Is it now OK to have sex with animals?
- 43 TV shows to watch in 2014
- In defense of Gwyneth Paltrow
- In Ferguson, Michael Brown lost his life — and America's police lost the benefit of the doubt
- Republicans love this new health care plan. Too bad it's basically a tax cut for the rich.
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- 17 old proverbs we should use more often
- 17 disgusting descriptions for delicious wines
- 8 tricks to surviving the holidays without gaining weight or being grouchy
- Chuck Hagel wasn't the problem. It's America's addiction to endless war.
Subscribe to the Week